# Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma

> **NCT03376737** · PHASE2 · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Lung Adenocarcinoma

## Interventions

- **DRUG:** Apatinib

## Key facts

- **NCT ID:** NCT03376737
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-12
- **Primary completion:** 2018-06
- **Final completion:** 2019-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03376737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03376737, "Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03376737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*